Hepatobiliary and Pancreatic Surgery (HPB) Program - Homepage

Carlos U. Corvera, MD, FACS

Professor of Surgery 
Division of Surgical Oncology 
Chief, Section of HPB-GISS (HepatoPancreatoBiliary, GI, Skin, Sarcoma Surgery) 
Maurice Galante Distinguished Professorship in Hepatobiliary Surgery

The Hepatobiliary and Pancreatic Surgery (HPB), GI, Skin, and Sarcoma Section (HPB-GISS) provides state-of-the-art treatment for patients with primary and metastatic cancers of the liver, gallbladder, bile duct and pancreas, in addition to surgical treatment for tumors of the gastrointestinal tract, skin, and soft tissues (sarcoma). The program also treats benign disease including cysts, biliary strictures and bile duct injuries.

Patients receive seamless multidisciplinary care from a team comprised of surgical oncologists, hepatobiliary surgeons, diagnostic radiologists, interventional radiologists, medical oncologists, hepatologists, gastroenterologists and anesthesiologists.

UCSF is one the few centers nationally that performs a large number of advanced laparoscopic and robotic liver and pancreas procedures. For liver, gallbladder and bile duct cancer cases requiring major resections, the group works seamlessly with our transplant surgeons to apply their expertise from living donor liver transplantation to perform complex reconstruction of the hepatic artery, portal vein or bile duct. This allows the HPB team to resect cancers involving major blood vessels which may be deemed inoperable at other centers. The Section also has expertise in regional approaches to advanced cancers, providing cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC), isolated limb infusion for sarcoma and melanoma (ILI), and is one of the most experienced hepatic artery infusion programs on the West Coast for patients with metastatic colorectal liver metastases and intrahepatic cholangiocarcinoma.

About Us